MARKET

ADXN

ADXN

Addex Therapeutics Ltd
NASDAQ
7.94
-0.15
-1.85%
Pre Market: 8.42 +0.48 +6.05% 06:22 01/08 EST
OPEN
8.09
PREV CLOSE
8.09
HIGH
8.37
LOW
7.70
VOLUME
397
TURNOVER
0
52 WEEK HIGH
12.05
52 WEEK LOW
6.51
MARKET CAP
9.78M
P/E (TTM)
-0.9480
1D
5D
1M
3M
1Y
5Y
1D
Addex Spin-Out Neurosterix Begins Phase 1 Trial of Schizophrenia Drug NTX-253
Reuters · 1d ago
Addex Therapeutics spin-out Neurosterix starts NTX-253 study
TipRanks · 1d ago
ADDEX SPIN-OUT NEUROSTERIX HAS STARTED A PHASE 1 CLINICAL STUDY WITH M4 PAM - NTX-253 FOR SCHIZOPHRENIA
Reuters · 1d ago
Addex Affiliate Neurosterix Launches Phase 1 Trial for Schizophrenia Drug
Reuters · 1d ago
Weekly Report: what happened at ADXN last week (1229-0102)?
Weekly Report · 3d ago
Weekly Report: what happened at ADXN last week (1222-1226)?
Weekly Report · 12/29/2025 10:31
Weekly Report: what happened at ADXN last week (1215-1219)?
Weekly Report · 12/22/2025 10:31
Weekly Report: what happened at ADXN last week (1208-1212)?
Weekly Report · 12/15/2025 10:39
More
About ADXN
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. It also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.

Webull offers Addex Therapeutics Ltd - ADR stock information, including NASDAQ: ADXN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADXN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADXN stock methods without spending real money on the virtual paper trading platform.